A new survey finds that nearly 7 in 10 Houstonians have skipped medical care due to high costs, putting them at risk for poor health outcomes. Photo via Getty Images

If you have felt like everything is getting more expensive lately — even at the doctor’s office or picking up your prescriptions — you’re not alone.

New survey data from health marketplace Sesame shows that Houston residents are on the front lines of the health care affordability crisis. Though the uninsured rate nationwide is at a record low, there are still more than 26 million Americans without any health insurance — and millions more on high-deductible health plans (HDHPs). Since tens of millions of Americans are either uninsured or underinsured, it’s no surprise that local residents are feeling the pinch in their wallet with medical expenses — and many are holding off on making their annual doctor’s appointments as a result.

Let’s break down the data a bit further:

In a survey of 450 Houston-based consumers, ages 18 and over, 68 percent of respondents admitted they have skipped a doctor’s appointment, 59 percent have skipped filling a prescription, 55 percent have avoided getting an x-ray or lab, and 68 percent skip the dentist — all due to high costs. These numbers are shockingly even higher for Houstonians with chronic medical conditions — with 74 percent skipping the doctor or dentist, 68 percent holding off on prescriptions and 63 percent avoiding x-rays or labs.

Almost all respondents (92 percent) say that rising gas prices and inflation are impacting their ability to afford essential items like rent/mortgage payments or medical bills — and 65 percent feel extremely impacted by these forces. As a result, 79 percent are cutting back on transportation expenses, 80 percent have cut back on grocery and food expenses – and 59 percent admit they have cut back on medical expenses like filling prescriptions or going to the doctor.

Skipping or delaying medical care can have serious consequences, according to researchers. A Harvard T.H. Chan School of Public Health study found that 57 percent of Americans who delayed medical care reported negative health consequences as a result. Experts estimate an additional 10,000 deaths from colon and breast cancer over the next 10 years, due to missed screenings during 2020 alone.

Medical debt is another issue plaguing local residents. Nearly half (48 percent) of those surveyed have medical debt. Of those with debt, 57 percent have more than $1,000 in debt and almost a quarter owe more than $5,000. Medical debt often happens as a result of surprise medical bills, of which 52 percent of Houstonians have received in the last year. The new No Surprises Act passed this year should help with some of these concerns in the future, but it’s important to understand what is protected and what isn’t.

Finally, 15 percent of respondents say they don’t have a primary care doctor, and 9 percent of those with chronic conditions do not. More than a third of respondents did not have an annual physical this year. Cost, lack of transportation and lack of time away from home or work were cited as the biggest barriers to care.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Austin company to bring AI-powered school to The Woodlands

AI education

Austin-based Alpha School, which operates AI-powered private schools, is opening its first Houston-area location in The Woodlands.

The 8,000-square-foot school, scheduled to be ready for the 2026-27 academic year, initially will serve students in kindergarten through eighth grade. Alpha says the school will offer “open workshop spaces and innovative classrooms that support personalized instruction, core academics, leadership development, and real-world life skills.”

Alpha sets aside two hours each school day for the AI-driven, self-paced study of core subjects like math, reading and science. The rest of each school day consists of life-skills workshops focusing on topics such as leadership and financial literacy.

Alpha’s school in The Woodlands has begun accepting applications for the 2026-27 school year. Annual tuition costs $40,000.

“The Woodlands is one of the most dynamic, forward-thinking communities in Texas, and Alpha is proud to bring

an innovative educational model that complements its strong academic foundation,” says Rachel Goodlad, head

of expansion for Alpha.

Founded in 2014, Alpha School combines adaptive technology-driven instruction with immersive life-skills workshops. Its model emphasizes mastery-based learning in core subjects alongside development of communication, critical thinking, financial literacy and leadership skills. It operates more than 15 schools across the country.

Elsewhere in Texas, Alpha operates schools in Austin, Brownsville, Fort Worth and Plano. Alpha also operates 12 Texas Sports Academy campuses in Texas, including locations in Houston, Pearland and Richmond, along with a NextGen Academy esports school in Austin, a school for gifted students in Georgetown, and lower-cost Nova Academy campuses in Austin and Bastrop.

Alpha has fans and critics. While supporters tout students’ high achievement rates, detractors complain about the high tuition and the AI-influenced depersonalization of education.

“Students and our country need to be in relationship with other human beings,” Randi Weingarten, president of the American Federation of Teachers, a teachers union, tells The New York Times. “When you have a school that is strictly AI, it is violating that core precept of the human endeavor and of education.”

Alpha co-founder MacKenzie Price, a podcaster and social media influencer, doesn’t share Weingarten’s views.

“Parents and teachers: We need to embrace this change,” Price wrote after President Trump signed an executive order promoting AI in schools.

The Times notes that Alpha doesn’t employ AI as a tutor or a supplement. Rather, the newspaper says, AI is “the school’s primary educational driver to move students through academic content.”

Houston researcher secures $1.7M to develop drug for aggressive form of breast cancer

cancer research

A University of Houston researcher has joined a $3.2 million effort to develop a new drug designed to attack a cancer-driving protein commonly found in triple-negative breast cancer.

Triple-negative breast cancer (TNBC) is one of the most difficult-to-treat forms of cancer and accounts for 10 percent to 15 percent of all breast cancer cases. The disease gets its name because tumors associated with it test negative for estrogen receptors, progesterone receptors and excess HER2 protein, making it difficult to target. Due to this, TNBC is often treated with general chemotherapy, which can come with negative side effects and drug resistance, according to UH.

UH College of Pharmacy research associate professor Wei Wang is developing a drug that can target the disease more specifically. The drug will target MDM2, a protein often overproduced in TNBC that also contributes to faster tumor growth.

Wang is working on a team led by Wei Li, director of the University of Tennessee Health Science Center College of Pharmacy’s Drug Discovery Center. She has received $1.7 million to support the research.

Wang and UH professor of pharmacology and toxicology Ruiwen Zhang have discovered a compound that can break down MDM2. In early laboratory models, the compound has shown the ability to shrink tumors.

Wang and Zhang will focus on understanding how the treatment works and monitoring its effectiveness in models that closely mirror human disease.

“We will study how the drug targets MDM2 and evaluate the most promising drug candidates to determine effective dosing, understand how the drug behaves in the body, compare it with existing treatments and assess early safety,” Wang said in a news release.

Li’s team at the University of Tennessee will be working on the chemistry and drug design end of the project.

“This work could lead to an entirely new class of therapies for triple-negative breast cancer,” Li added in the release. “We’re hopeful that by directly removing the MDM2 protein from cancer cells, we can help more patients respond to treatment regardless of their tumor type.”